Susceptibilities of Bordetella pertussis strains to antimicrobial peptides

30Citations
Citations of this article
31Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

We examined the susceptibilities of Bordetella pertussis strains to several antimicrobial peptides by determining the concentration required to inhibit or kill 50% of the bacterial population. The peptides are ranked in decreasing potency as follows: cecropin B > cecropin A >> melittin > cecropin P1 > (ala8,13,18)-magainin II amide > mastoparan = defensin HNP1 > protamine ≥ magainin II = magainin I. By using a radial diffusion assay to compare susceptibilities between strains, wild-type B. pertussis BP338 was more resistant than the avirulent bvg mutant strain BP347 and the brk mutant strain BPM2041 to killing by cecropin P1. In contrast, compared with the wild type, the avirulent BP347 strain was highly resistant to killing by protamine and defensin HNP1.

Cite

CITATION STYLE

APA

Fernandez, R. C., & Weiss, A. A. (1996). Susceptibilities of Bordetella pertussis strains to antimicrobial peptides. Antimicrobial Agents and Chemotherapy. American Society for Microbiology. https://doi.org/10.1128/aac.40.4.1041

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free